pharmaceutical preparations, namely, cell adhesion modulating agents for use in the treatment of cancer, endometriosis, macular degeneration and other [angiogensis-dependent] * angiogenesis-dependent * conditions, multiple sclerosis and other demyelinating diseases, spinal cord injury, obesity, and hair loss; therapeutic preparations, namely, cell adhesion modulating agents for use in drug delivery systems for facilitating the transmission of agents through human tissue; and diagnostic preparations, namely, cell adhesion modulating agents for use in medical diagnostic reagents

'adhes':5,44,67 'agent':7,46,58,69 'angiogenesi':24 'angiogenesis-depend':23 'angiogensi':21 'angiogensis-depend':20 'cancer':14 'cell':4,43,66 'condit':26 'cord':34 'degener':17 'deliveri':51 'demyelin':31 'depend':22,25 'diagnost':63,74 'diseas':32 'drug':50 'endometriosi':15 'facilit':54 'hair':38 'human':60 'injuri':35 'loss':39 'macular':16 'medic':73 'modul':6,45,68 'multipl':27 'name':3,42,65 'obes':36 'pharmaceut':1 'prepar':2,41,64 'reagent':75 'sclerosi':28 'spinal':33 'system':52 'therapeut':40 'tissu':61 'transmiss':56 'treatment':12 'use':9,48,71

ADHEREX

Owners

Goods & Services